Sawgrass Asset Management’s Select Medical SEM Stock Holding History

Sawgrass Asset Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-24,536	Closed	-$243K	–	230
2018 Q3	$243K	Sell	24,536 -46,818	-66%	-$485K	0.01%	201
2018 Q2	$698K	Buy	71,354 +29,510	+71%	+$290K	0.03%	144
2018 Q1	$389K	Buy	41,844 +6,302	+18%	+$60K	0.02%	162
2017 Q4	$338K	Buy	+35,542	New	+$340K	0.02%	176

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Sawgrass Asset Management's SEM Position: Q4 2018 in Review

Sawgrass Asset Management sold out of Select Medical (SEM) in Q4 2018, closing a stake of 24,536 shares — an estimated $243K sold.

Sawgrass Asset Management first reported a position in SEM in Q4 2017 and held it in 4 quarters. The position peaked at $698K in Q2 2018. 208 funds tracked by Wall St. Rank hold SEM as of Q4 2018.

Sawgrass Asset Management reported no remaining Select Medical position as of Q4 2018 after selling out during the quarter.
Sawgrass Asset Management sold 24,536 Select Medical shares in Q4 2018, an estimated $243K.
Sawgrass Asset Management first reported a position in Select Medical in Q4 2017 and held it in 4 quarters.
Sawgrass Asset Management's Select Medical position peaked at $698K in Q2 2018.
208 funds tracked by Wall St. Rank held Select Medical as of Q4 2018.

Based on Sawgrass Asset Management's 13F filing for Q4 2018, filed 1 Feb 2019.